AAPL   383.82 (+0.64%)
CGC   16.09 (-1.47%)
TSLA   1,379.20 (+0.98%)
AMD   54.95 (+2.84%)
BAC   22.71 (-1.73%)
NFLX   503.73 (+0.19%)
BA   176.16 (-2.18%)
AAPL   383.82 (+0.64%)
CGC   16.09 (-1.47%)
TSLA   1,379.20 (+0.98%)
AMD   54.95 (+2.84%)
BAC   22.71 (-1.73%)
NFLX   503.73 (+0.19%)
BA   176.16 (-2.18%)
AAPL   383.82 (+0.64%)
CGC   16.09 (-1.47%)
TSLA   1,379.20 (+0.98%)
AMD   54.95 (+2.84%)
BAC   22.71 (-1.73%)
NFLX   503.73 (+0.19%)
BA   176.16 (-2.18%)
AAPL   383.82 (+0.64%)
CGC   16.09 (-1.47%)
TSLA   1,379.20 (+0.98%)
AMD   54.95 (+2.84%)
BAC   22.71 (-1.73%)
NFLX   503.73 (+0.19%)
BA   176.16 (-2.18%)
Log in

NYSE:CLColgate-Palmolive Stock Price, Forecast & News

$74.31
-0.18 (-0.24 %)
(As of 07/9/2020 10:17 AM ET)
Add
Compare
Today's Range
$74.01
Now: $74.31
$74.62
50-Day Range
$69.25
MA: $72.34
$74.36
52-Week Range
$58.49
Now: $74.31
$77.41
Volume349,283 shs
Average Volume3.59 million shs
Market Capitalization$63.65 billion
P/E Ratio25.38
Dividend Yield2.38%
Beta0.6
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners. The company also provides home care products comprising dishwashing detergents, household cleaners, and fabric conditioners; pet nutrition products for everyday nutritional needs; and a range of therapeutic products to manage disease conditions in dogs and cats. Its principal global and regional trademarks include Colgate, Palmolive, elmex, Tom's of Maine, Sorriso, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sanex, Elta MD, PCA Skin, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. The company markets and sells its oral, personal, and home care products to various retailers, wholesalers, and distributors; and pet nutrition products for dogs and cats through pet supply retailers, veterinarians, and e-commerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Read More
Colgate-Palmolive logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.2Community Rank: 1.8Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.89 out of 5 stars


Industry, Sector and Symbol

Industry Toilet preparations
Sub-IndustryHousehold Products
CUSIP19416210
Phone212-310-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.69 billion
Cash Flow$3.47 per share
Book Value$0.65 per share

Profitability

Net Income$2.37 billion

Miscellaneous

Employees34,300
Market Cap$63.65 billion
Next Earnings Date7/31/2020 (Confirmed)
OptionableOptionable

Receive CL News and Ratings via Email

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.

Colgate-Palmolive (NYSE:CL) Frequently Asked Questions

How has Colgate-Palmolive's stock been impacted by COVID-19 (Coronavirus)?

Colgate-Palmolive's stock was trading at $68.90 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CL shares have increased by 8.3% and is now trading at $74.59. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Colgate-Palmolive?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Colgate-Palmolive.

When is Colgate-Palmolive's next earnings date?

Colgate-Palmolive is scheduled to release its next quarterly earnings announcement on Friday, July 31st 2020. View our earnings forecast for Colgate-Palmolive.

How can I listen to Colgate-Palmolive's earnings call?

Colgate-Palmolive will be holding an earnings conference call on Friday, July 31st at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) issued its earnings results on Friday, May, 1st. The company reported $0.75 earnings per share for the quarter, topping the consensus estimate of $0.73 by $0.02. The business had revenue of $4.10 billion for the quarter, compared to the consensus estimate of $4.07 billion. Colgate-Palmolive had a net margin of 15.86% and a return on equity of 942.99%. The company's revenue was up 5.5% on a year-over-year basis. During the same period last year, the business earned $0.67 earnings per share. View Colgate-Palmolive's earnings history.

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive announced a quarterly dividend on Thursday, June 11th. Investors of record on Monday, July 20th will be paid a dividend of $0.44 per share on Friday, August 14th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.36%. The ex-dividend date is Friday, July 17th. View Colgate-Palmolive's dividend history.

What price target have analysts set for CL?

15 Wall Street analysts have issued twelve-month price objectives for Colgate-Palmolive's shares. Their forecasts range from $58.00 to $91.00. On average, they anticipate Colgate-Palmolive's share price to reach $75.54 in the next year. This suggests a possible upside of 1.3% from the stock's current price. View analysts' price targets for Colgate-Palmolive.

Has Colgate-Palmolive been receiving favorable news coverage?

Media headlines about CL stock have trended negative this week, InfoTrie reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Colgate-Palmolive earned a news impact score of -2.1 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Colgate-Palmolive.

Are investors shorting Colgate-Palmolive?

Colgate-Palmolive saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 12,560,000 shares, a decline of 6.8% from the June 15th total of 13,470,000 shares. Based on an average trading volume of 4,580,000 shares, the days-to-cover ratio is currently 2.7 days. Approximately 1.5% of the shares of the stock are short sold. View Colgate-Palmolive's Current Options Chain.

Who are some of Colgate-Palmolive's key competitors?

What other stocks do shareholders of Colgate-Palmolive own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), PepsiCo (PEP), AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Walt Disney (DIS), Coca-Cola (KO), Mcdonald's (MCD) and Intel (INTC).

Who are Colgate-Palmolive's key executives?

Colgate-Palmolive's management team includes the following people:
  • Mr. Ian M. Cook, Exec. Chairman (Age 66)
  • Mr. Noel R. Wallace, Pres, CEO & Director (Age 55)
  • Mr. Henning I. Jakobsen, Chief Financial Officer (Age 59)
  • Mr. P. Justin Skala, Exec. VP and Chief Growth & Strategy Officer (Age 59)
  • Dr. Patricia D. Verduin Ph.D., Chief Technology Officer (Age 60)

What is Colgate-Palmolive's stock symbol?

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Who are Colgate-Palmolive's major shareholders?

Colgate-Palmolive's stock is owned by a variety of institutional and retail investors. Top institutional investors include Confluence Investment Management LLC (0.19%), Envestnet Asset Management Inc. (0.04%), State of Alaska Department of Revenue (0.02%), Cullinan Associates Inc. (0.02%), DNB Asset Management AS (0.01%) and Private Asset Management Inc. (0.01%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Michael B Polk, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove. View institutional ownership trends for Colgate-Palmolive.

Which institutional investors are selling Colgate-Palmolive stock?

CL stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, Legacy Capital Partners Inc., Global Trust Asset Management LLC, M&R Capital Management Inc., Ipswich Investment Management Co. Inc., First Financial Bank Trust Division, Private Asset Management Inc., and Truehand Inc. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Helene D Gayle, Henning I Jakobsen, Ian M Cook, John J Huston, John T Cahill, John W Kooyman, Michael B Polk, Noel R Wallace, Patricia Verduin, Philip G Shotts, and Prabha Parameswaran. View insider buying and selling activity for Colgate-Palmolive.

Which institutional investors are buying Colgate-Palmolive stock?

CL stock was bought by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., First American Trust FSB, State of Alaska Department of Revenue, Livforsakringsbolaget Skandia Omsesidigt, Pure Financial Advisors Inc., Bangor Savings Bank, DNB Asset Management AS, and Private Trust Co. NA. View insider buying and selling activity for Colgate-Palmolive.

How do I buy shares of Colgate-Palmolive?

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Colgate-Palmolive's stock price today?

One share of CL stock can currently be purchased for approximately $74.59.

How big of a company is Colgate-Palmolive?

Colgate-Palmolive has a market capitalization of $63.89 billion and generates $15.69 billion in revenue each year. The company earns $2.37 billion in net income (profit) each year or $2.83 on an earnings per share basis. Colgate-Palmolive employs 34,300 workers across the globe.

What is Colgate-Palmolive's official website?

The official website for Colgate-Palmolive is www.colgatepalmolive.com.

How can I contact Colgate-Palmolive?

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.